Related Experiment Video

Updated: Jun 11, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

Molecular and clinical aspects of targeting the VEGF pathway in tumors

Grzegorz Korpanty1, Laura A Sullivan, Elizabeth Smyth

  • 1Department of Medical Oncology, Mater Misericordiae University Hospital, Eccles St, Dublin 7, Ireland.

Journal of Oncology
|July 15, 2010
PubMed

Insights

Targeting tumor angiogenesis with antiangiogenic therapy shows promise but faces challenges. Further research into tumor signaling and response tracking is crucial for improving cancer treatment efficacy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Tumor angiogenesis is a critical process driven by tumor microenvironment signals.
  • Antiangiogenic therapies, including bevacizumab, sorafenib, and sunitinib, are clinically used but have limitations.
  • Significant questions remain regarding the efficacy and mechanisms of current antiangiogenic treatments.

Purpose of the Study:

  • To explore the complex signaling pathways involved in tumor angiogenesis.
  • To identify novel therapeutic targets for antiangiogenic therapy.
  • To develop tools for monitoring tumor response to antiangiogenic treatments.

Main Methods:

  • Review of preclinical and clinical studies on tumor angiogenesis.
  • Analysis of signaling cascades promoting tumor vascularization.
  • Discussion of methodologies for tracking therapeutic responses.

Main Results:

  • Current antiangiogenic therapies, while advanced, do not meet all therapeutic expectations.
  • Understanding tumor angiogenesis signaling is key to overcoming treatment limitations.
  • Reliable response-tracking tools are needed to assess efficacy and predict patient outcomes.

Conclusions:

  • Continued investigation of tumor angiogenesis signaling pathways is essential for developing improved anti-cancer strategies.
  • Developing methods to monitor treatment response will enhance the understanding and application of antiangiogenic therapies.
  • Future research should focus on refining targets and predictive tools for personalized antiangiogenic treatment.

More Related Videos

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...